Cargando…

Reprogramming the Canine Glioma Microenvironment with Tumor Vaccination plus Oral Losartan and Propranolol Induces Objective Responses

PURPOSE: Malignant gliomas have a highly immune-suppressive tumor microenvironment (TME) which renders them largely unresponsive to conventional therapeutics. Therefore, the current study evaluated a therapeutic protocol designed to overcome the immune barrier by combining myeloid cell–targeted immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ammons, Dylan T., Guth, Amanda, Rozental, Aaron J., Kurihara, Jade, Marolf, Angela J., Chow, Lyndah, Griffin, John F., Makii, Rebecca, MacQuiddy, Brittany, Boss, Mary-Keara, Regan, Daniel P., Frank, Chad, McGrath, Stephanie, Packer, Rebecca A., Dow, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835010/ https://www.ncbi.nlm.nih.gov/pubmed/36644324 http://dx.doi.org/10.1158/2767-9764.CRC-22-0388

Ejemplares similares

Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction
por: MacQuiddy, Brittany, et al.
Publicado: (2022)

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
por: Regan, Daniel P., et al.
Publicado: (2022)

Generation of Neural Progenitor Cells From Canine Induced Pluripotent Stem Cells and Preliminary Safety Test in Dogs With Spontaneous Spinal Cord Injuries
por: Chow, Lyndah, et al.
Publicado: (2020)

Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs
por: Ammons, Dylan, et al.
Publicado: (2023)

Canine polarized macrophages express distinct functional and transcriptomic profiles
por: Chow, Lyndah, et al.
Publicado: (2022)

Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy
por: Boss, Mary-Keara, et al.
Publicado: (2022)

A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs
por: Ammons, Dylan T., et al.
Publicado: (2023)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
por: Wheat, William, et al.
Publicado: (2019)

Evaluation of Immune Nanoparticles for Rapid and Non-Specific Activation of Antiviral and Antibacterial Immune Responses in Cattle, Swine, and Poultry
por: Wheat, William H., et al.
Publicado: (2023)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose‐Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model
por: Soontararak, Sirikul, et al.
Publicado: (2018)

Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections
por: Johnson, Valerie, et al.
Publicado: (2017)

Use of Handheld Raman Spectroscopy for Intraoperative Differentiation of Normal Brain Tissue From Intracranial Neoplasms in Dogs
por: Doran, Caitlin E., et al.
Publicado: (2022)

Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research
por: Boss, Mary-Keara, et al.
Publicado: (2023)

Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
por: Cao, Jennifer, et al.
Publicado: (2023)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Subglottic Hemangioma Treated With Propranolol
por: Hardison, Scott A., et al.
Publicado: (2014)

Propranolol for the treatment of vascular sarcomas
por: Wagner, Michael J, et al.
Publicado: (2018)

Trichodynia Silenced Effectively with Propranolol
por: Brzezinski, Piotr, et al.
Publicado: (2019)

Propafenone and propranolol dual toxicity
por: Farooq, Moonis, et al.
Publicado: (2020)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology
por: Nolan, Michael W., et al.
Publicado: (2019)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

Losartan Interactions with 2-Hydroxypropyl-β-CD
por: Palli, Vasiliki, et al.
Publicado: (2022)

A Case Report of Losartan Induced Angioedema
por: Vedantam, Venkata, et al.
Publicado: (2023)

Anti-Epileptogenesis: Some Roads Lead to Losartan
por: Sarkis, Rani A.
Publicado: (2023)

Losartan-Induced Angioedema: A Case Report
por: Mann, Henry, et al.
Publicado: (2023)

Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis
por: STILES, JESSICA, et al.
Publicado: (2012)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
por: Yoon, Deok Yong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hkmpu3110e6q1e1i8kb6ddaqkd